Niamh Coleman - University of Texas MD Anderson Cancer Center

基本信息

Career Trajectory

Bio

Niamh Coleman, MBBCH BAO PhD, is a fellow in the Department of Investigational Cancer Therapeutics (Phase I Program) Oncology at the University of Texas MD Anderson Cancer Center (MDACC). She undertook her medical oncology training in Ireland and completed Higher Specialist Training in Medical Oncology in Ireland in July 2017. Dr. Coleman pursued an extended period of clinical research, including a fellowship in phase I drug development and a translational PhD at the Royal Marsden Hospital.

Research Interests

Papers共 77 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

EV021/#894 Mutational Analysis of Circulating Tumour DNA (ctdna) in High Grade Serous Ovarian Cancer (HGSC) Using Cancer Personalised Profiling by Deep Sequencing (Capp-Seq)

Mark Ward,Tanya Kelly,Faye Lewis,Catherine O’Gorman,Brian Henderson,Sinead Hurley, Marika Kanjuga, Emer Atkinson,Cathal O’Brien,Patrick Maguire,Waseem Kamran,James Beirne,Niamh Coleman,Karen Cadoo,Feras Abu Saadeh,Lucy Norris,Cara Martin,John O’Leary,Sharon O’Toole

International Journal of Gynecological Cancer (2024): A94

Cited0Views0Bibtex

FIGURE 2 from Phase I Study of Mtorc1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with Mtor/akt/pi3k Pathway Alterations and Advanced Solid Malignancies

Vivek Subbiah,Niamh Coleman,Sarina A. Piha-Paul,Apostolia M. Tsimberidou,Filip Janku,Jordi Rodon,Shubham Pant,Ecaterina E. Ileana Dumbrava,Siqing Fu,David S. Hong,Shizhen Zhang,Ming Sun,Yunfang Jiang,Jason Roszik,Juhee Song,Ying Yuan, Funda Meric-Bernstam,Aung Naing

crossref（2024）

Cited0Views0Bibtex

337 (PB325): Poly(ADP-Ribose) Polymerase (PARP) Inhibition in Metastatic Breast Cancer: Comparison of Therapeutic Outcomes Between Patients with BRCA1/2 Mutations and Other Alterations

N. Coleman,N.Y.L. Ngoi, D. Nguyen, B. Nelson, E. Dumbrava,S. Fu,D.S. Hong,D. Karp,A. Naing,S.A. Piha-Paul,J. Rodon,A. Tsimberidou-,B. Lim, P. Pohlman,F. Meric-Bernstam,J.K. Litton,B. Arun,T.A. Yap

European Journal of Cancer (2024): 114850

Cited0Views0Bibtex

Challenges and Opportunities in the Immunotherapy Era: Balancing Expectations with Hope in Small-Cell Lung Cancer

Raza Khan,Niamh Coleman

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024)

Cited1Views0WOSBibtex

Phase I Study of Sapanisertib (CB‐228/TAK‐228/MLN0128) in Combination with Ziv‐aflibercept in Patients with Advanced Solid Tumors

Niamh Coleman,Bettzy Stephen,Siqing Fu,Daniel Karp,Vivek Subbiah,Jordi Rodon Ahnert,Sarina A. Piha-Paul,John Wright, Senait N. Fessahaye,Fengying Ouyang,Bulent Yilmaz,Funda Meric-Bernstam,Aung Naing

CANCER MEDICINE（2024）

Cited1Views0WOSBibtex

Targeting Rare Variants of a Pan-Cancer Target: the Landscape of BRAF Non-V600 Mutations and BRAFfusions from 172,005 Adult Patients with Cancer

Niamh Coleman, Vivek Subbiah

Journal of Clinical Oncology（2024）

Cited0Views0Bibtex

Poly(ADP-Ribose) Polymerase (PARP) Inhibition in Metastatic Breast Cancer: Comparison of Therapeutic Outcomes Between Patients with BRCA1/2 Mutations and Other Alterations

N. Coleman,N. Y. L. Ngoi, D. Nguyen, B. Nelson, E. Dumbrava,S. Fu,D. S. Hong,D. Karp,A. Naing,S. A. Piha-Paul,J. Rodon,A. Tsimberidou,B. Lim, P. Pohlman,F. Meric-Bernstam,J. K. Litton,B. Arun,T. A. Yap

EUROPEAN JOURNAL OF CANCER (2024): S127-S127

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn